Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeline Not

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Neurology|September 4, 2024
Nonamyloidogenic TTR gene variants c.76G>A and c.337-18G>C are not associated with idiopathic small-fiber neuropathyCéline Konecki, Bruno Francou, Kenneth Chappell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, et al.
European Journal of Human Genetics : EJHG|April 19, 2019
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2Alessia Peretti, Maud Perie, Didier Vincent, et al.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Neurology|September 4, 2024
Nonamyloidogenic TTR gene variants c.76G>A and c.337-18G>C are not associated with idiopathic small-fiber neuropathyCéline Konecki, Bruno Francou, Kenneth Chappell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, et al.
European Journal of Human Genetics : EJHG|April 19, 2019
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2Alessia Peretti, Maud Perie, Didier Vincent, et al.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Pageof 2